174 related articles for article (PubMed ID: 30965050)
1. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
Ikemura N; Yamaori S; Kobayashi C; Kamijo S; Murayama N; Yamazaki H; Ohmori S
Chem Biol Interact; 2019 Jun; 306():1-9. PubMed ID: 30965050
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
[TBL] [Abstract][Full Text] [Related]
3. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
4. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
Karkhanis A; Lam HY; Venkatesan G; Koh SK; Chai CL; Zhou L; Hong Y; Kojodjojo P; Chan EC
Biochem Pharmacol; 2016 May; 107():67-80. PubMed ID: 26972388
[TBL] [Abstract][Full Text] [Related]
5. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions.
Uesawa Y; Takeuchi T; Mohri K
Curr Pharm Biotechnol; 2012 Jul; 13(9):1705-17. PubMed ID: 22039822
[TBL] [Abstract][Full Text] [Related]
7. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
Lee E; Wu Z; Shon JC; Liu KH
Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
[TBL] [Abstract][Full Text] [Related]
8. The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2.
Tian X; Zhou M; Ning J; Deng X; Feng L; Huang H; Yao D; Ma X
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):737-748. PubMed ID: 33682565
[TBL] [Abstract][Full Text] [Related]
9. Effect of benidipine on simvastatin metabolism in human liver microsomes.
Sugiyama Y; Mimura N; Kuwabara T; Kobayashi H; Ushiki J; Fuse E
Drug Metab Pharmacokinet; 2007 Jun; 22(3):199-205. PubMed ID: 17603221
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
Katoh M; Nakajima M; Yamazaki H; Yokoi T
Pharm Res; 2000 Oct; 17(10):1189-97. PubMed ID: 11145223
[TBL] [Abstract][Full Text] [Related]
11. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
[TBL] [Abstract][Full Text] [Related]
12. The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle.
Zhu HL; Tomoda T; Aishima M; Ito Y; Teramoto N
Br J Pharmacol; 2006 Nov; 149(6):786-96. PubMed ID: 17016499
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2.
Xu MJ; Jiang LF; Wu T; Chu JH; Wei YD; Aa JY; Wang GJ; Hao HP; Ju WZ; Li P
Chem Biol Interact; 2018 Jun; 289():15-22. PubMed ID: 29689254
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
Park SH; Lee J; Shon JC; Phuc NM; Jee JG; Liu KH
Phytomedicine; 2018 Mar; 42():199-206. PubMed ID: 29655687
[TBL] [Abstract][Full Text] [Related]
15. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
Fujisawa M; Yorikane R; Matsuoka Y; Koike H; Ueno K
J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
[TBL] [Abstract][Full Text] [Related]
16. Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice.
Uesawa Y; Mohri K
Yakugaku Zasshi; 2008 Jan; 128(1):117-22. PubMed ID: 18176062
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Ren S; Zeng J; Mei Y; Zhang JZ; Yan SF; Fei J; Chen L
Drug Metab Dispos; 2013 Jan; 41(1):60-71. PubMed ID: 23033255
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
[TBL] [Abstract][Full Text] [Related]
19. Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.
Lin HL; Zhang H; Walker VJ; D'Agostino J; Hollenberg PF
Drug Metab Dispos; 2017 Sep; 45(9):990-999. PubMed ID: 28698302
[TBL] [Abstract][Full Text] [Related]
20. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S
Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
